Larvol Delta - Cartesian-Therapeutics-Secures-up-to-150-Million-of-NonDilutive-Financing-from-K2-HealthVentures-and-Expects-Topline-Data-from-the-Phase-3-AURORA-Trial-in-First-Quarter-2027

Descartes-08 - Cartesian Therapeutics

https://www.globenewswire.com/news-release/2026/05/26/3300928/0/en/cartesian-therapeutics-secures-up-to-150-million-of-non-dilutive-financing-from-k2-healthventures-and-expects-topline-data-from-the-phase-3-aurora-trial-in-first-quarter-2027.html

May 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next